Ryan Merkow to Chemotherapy, Adjuvant
This is a "connection" page, showing publications Ryan Merkow has written about Chemotherapy, Adjuvant.
Connection Strength
1.254
-
Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer. Ann Surg. 2014 Aug; 260(2):372-7.
Score: 0.425
-
Safety and feasibility of establishing an adjuvant hepatic artery infusion program. HPB (Oxford). 2024 05; 26(5):656-663.
Score: 0.203
-
Utilization of Minimally Invasive Surgery and Its Association with Chemotherapy for Locally Advanced Gastric Cancer. J Gastrointest Surg. 2020 02; 24(2):243-252.
Score: 0.153
-
National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resection. Ann Surg Oncol. 2020 Mar; 27(3):909-918.
Score: 0.153
-
Failure to administer recommended chemotherapy: acceptable variation or cancer care quality blind spot? BMJ Qual Saf. 2020 02; 29(2):103-112.
Score: 0.150
-
Effect of postoperative complications on adjuvant chemotherapy use for stage III colon cancer. Ann Surg. 2013 Dec; 258(6):847-53.
Score: 0.101
-
The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S500-8.
Score: 0.024
-
Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States. Ann Surg Oncol. 2013 Feb; 20(2):362-70.
Score: 0.023
-
Incorporation of adjuvant therapy into the multimodality management of gastrointestinal stromal tumors of the stomach in the United States. Ann Surg Oncol. 2012 Jan; 19(1):184-91.
Score: 0.021